ME1 45.0% 2.2¢ melodiol global health limited

Ann: Halucenex Phase II Clinical Trial Update, page-12

  1. 267 Posts.
    lightbulb Created with Sketch. 52
    Sample size of 5 omg
    I’m tipping this wasn’t peer reviewed or even published anywhere ,, also the first report Dec 2022 said there were 20 participants ,, did the others end there life due to investing with creso? Was that the initial trauma they all unfortunately suffered ? few on this forum and beyond certainly need something for The ptsd suffered from ever investing in this company and the fraud squad runnin it but with no scientific data no paper no background info no baseline-post results basically no participants and 1 paragraph written most likely by Blumenthal I have some doubt psychobilin will help
 
watchlist Created with Sketch. Add ME1 (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
-0.018(45.0%)
Mkt cap ! $838K
Open High Low Value Volume
4.0¢ 4.1¢ 2.2¢ $185.3K 6.400M

Buyers (Bids)

No. Vol. Price($)
4 250580 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 83515 1
View Market Depth
Last trade - 14.12pm 19/06/2024 (20 minute delay) ?
ME1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.